Australia
Locksley Announces Oversubscribed A$17 Million Placement Lead by U.S. Investors Funding to Accelerate Execution of Locksley's U.S. Mine to Market Strategy
SAN BERNARDINO, Calif., Dec. 8, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY/OTCQX: LKYRF/ADR: LKYLY) announced the successful completion of a heavily oversubscribed capital raising, securing firm commitments to raise approximatelyA$17 million via a placement of new shares at A$0.24 ...
2025-12-08 21:30
2593
Yantai offers global bay areas a paradigm of low-carbon transformation
YANTAI, China, Dec. 8, 2025 /PRNewswire/ -- On December 4, the 2025 Shandong Green Low-carbon High-quality Development Conference was held in Yantai,Shandong province. Against the backdrop of the fifth anniversary ofChina's 'dual carbon' goals, Yantai's achievements—as one of the country's first ...
2025-12-08 16:52
1226
X-Design Takes #1 on Product Hunt with AI Agent That Democratizes Branding for Local Businesses
SYDNEY, Dec. 3, 2025 /PRNewswire/ -- X-Design
2025-12-04 10:00
1477
X-Design Launched AI Agent: The Always-On Partner That Saves Small Business 70% of Branding time
SYDNEY, Dec. 2, 2025 /PRNewswire/ -- For small business owners, building a
beautiful, consistent brand feels out of reach. Creating a logo
2025-12-03 10:10
1527
Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities
SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and accredited investors for a private placement of equity ...
2025-12-02 22:00
3288
Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours
* Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid tumors. * The collaboration includes precli...
2025-11-28 13:00
1400
Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy
SYDNEY, Nov. 18, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxali...
2025-11-19 05:15
3193
Seeing Machines launches world-first 'attention sharing' feature for enhanced distraction detection capability in commercial fleets
CANBERRA, Australia, Nov. 13, 2025 /PRNewswire/ -- Seeing Machines Limited, the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety announces the launch of its enhanced distraction detection feature, known as "attention shari...
2025-11-13 16:00
1285
TGE Pursues the Acquisition of the 100th Ritz Carlton Hotel Globally
PARIS, NEW YORK and SINGAPORE, Nov. 10, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that TGE has entered into ...
2025-11-10 22:25
2317
IR launches new observability-as-a-service platform Prognosis Elevate as hybrid IT complexity surges
Highlights: * Prognosis Elevate is observability-as-a-service for enterprises managing thousands of UC&C endpoints across multiple vendors. * Supports regulated sectors that must balance cloud agility with on-prem and data-residency compliance. * Backed by IR's global 24/7 DevOps and servic...
2025-11-04 10:01
1071
TINYBEANS ACQUIRES QEEPSAKE CREATING THE LEADING PRIVACY-FIRST FAMILY MEMORY PLATFORM
Tinybeans accelerates innovation in privacy-first, secure family memory-keeping SYDNEY, Nov. 3, 2025 /PRNewswire/ -- Tinybeans Group (ASX:TNY, OTCQB:TNYYF), the global privacy-first family photo-sharing and journaling app, today announced the acquisition of the assets of Qeepsake Inc., aBoston-ba...
2025-11-04 08:12
1990
Locksley Receives Up to US$191 Million Potential Support from EXIM for U.S. Critical Minerals Push
SAN BERNARDINO, Calif., Nov. 3, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY, OTCQX: LKYRF) announced the receipt of a Letter of Interest (LOI) from the Export-Import Bank ofthe United States (EXIM) outlining the intent to provide up toUS$191 million in potential project financing su...
2025-11-03 21:14
2023
The 2025 Conference on Wang Yangming Mind Philosophy opens in Yuyao, Ningbo
NINGBO, China, Oct. 30, 2025 /PRNewswire/ -- October 31 marks the birth
anniversary of the great Chinese philosopher Wang Yangming (1472-1529). On
October 30, the 2025 Conference on Wang Yangming Mind Philosophy was
inaugurated in Yuyao,Ningbo.
2025-10-31 04:37
1356
e-STORAGE Achieves Commercial Operation of 220 MWh Mannum Battery Energy Storage Project in South Australia
KITCHENER, ON, Oct. 29, 2025 /PRNewswire/ -- Canadian Solar Inc.
2025-10-29 19:00
2990
Myrio Therapeutics Announces Collaboration with Leading Research Institutions to Advance Solid Tumor T cell Immunotherapeutics
* Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to accelerate the development of next-generation T cell immunotherapies * Partnership with T cell experts Daniel J Powell Jr., PhD, and Mark Yarmarkov...
2025-10-28 19:35
945
Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner
SYDNEY, Oct. 27, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") today announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug Administration (FDA) to discuss overall survival (OS) findings in newly diagnosed glioblastoma (GBM) p...
2025-10-27 19:15
1965
Clarity signs copper-67 Supply Agreement with Nusano
SYDNEY, Oct. 16, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supp...
2025-10-16 21:04
2663
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia
* Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses * Phase 1/2 study to enroll ~500 healthy adults, with topline results expected by 2028 * We aim to build a universal Sarbecovirus vaccine platform to proactively address future pandemics SEONGNAM, South Kor...
2025-10-15 20:00
2044
Co-PSMA trial achieves primary endpoint
SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT...
2025-10-14 21:03
2602
Locksley Announces Major Advancement at Mojave as Structural Mapping Expands Scale of Antimony Target with a 400% Increase in Target Strike Length
SAN BERNARDINO, Calif., Oct. 10, 2025 /PRNewswire/ -- Locksley Resources, Ltd. (ASX: LKY; OTCQX: LKYRYF) announced that recent structural mapping has significantly expanded the scale of its target mineralized corridor at the Desert Antimony Mine (DAM) Prospect. A new parallel structural target wa...
2025-10-10 20:35
3593
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 322 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 291 media titles]
2026-02-24 16:13
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 288 media titles]
2026-02-23 10:09